Cargando…

Pulmonary embolism in a patient with neuroleptic malignant syndrome

Venous thromboembolism is one of the complications in patients prescribed antipsychotic medications. Neuroleptic malignant syndrome (NMS) is a rare side effect of antipsychotic medications in this population. In this case, a young patient, who presented with NMS after a recent start of antipsychotic...

Descripción completa

Detalles Bibliográficos
Autor principal: Almegren, Mosaad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297863/
https://www.ncbi.nlm.nih.gov/pubmed/30631408
http://dx.doi.org/10.4081/hr.2018.7753
_version_ 1783381218726772736
author Almegren, Mosaad
author_facet Almegren, Mosaad
author_sort Almegren, Mosaad
collection PubMed
description Venous thromboembolism is one of the complications in patients prescribed antipsychotic medications. Neuroleptic malignant syndrome (NMS) is a rare side effect of antipsychotic medications in this population. In this case, a young patient, who presented with NMS after a recent start of antipsychotic medications, had developed a pulmonary embolism despite standard of care measures of venous thromboprophylaxis and early mobilization. A low threshold of VTE suspicion and effective preventive measures are both required in order to avoid this preventable complication in this population.
format Online
Article
Text
id pubmed-6297863
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-62978632019-01-10 Pulmonary embolism in a patient with neuroleptic malignant syndrome Almegren, Mosaad Hematol Rep Case Report Venous thromboembolism is one of the complications in patients prescribed antipsychotic medications. Neuroleptic malignant syndrome (NMS) is a rare side effect of antipsychotic medications in this population. In this case, a young patient, who presented with NMS after a recent start of antipsychotic medications, had developed a pulmonary embolism despite standard of care measures of venous thromboprophylaxis and early mobilization. A low threshold of VTE suspicion and effective preventive measures are both required in order to avoid this preventable complication in this population. PAGEPress Publications, Pavia, Italy 2018-12-12 /pmc/articles/PMC6297863/ /pubmed/30631408 http://dx.doi.org/10.4081/hr.2018.7753 Text en ©Copyright M. Almegren , 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Case Report
Almegren, Mosaad
Pulmonary embolism in a patient with neuroleptic malignant syndrome
title Pulmonary embolism in a patient with neuroleptic malignant syndrome
title_full Pulmonary embolism in a patient with neuroleptic malignant syndrome
title_fullStr Pulmonary embolism in a patient with neuroleptic malignant syndrome
title_full_unstemmed Pulmonary embolism in a patient with neuroleptic malignant syndrome
title_short Pulmonary embolism in a patient with neuroleptic malignant syndrome
title_sort pulmonary embolism in a patient with neuroleptic malignant syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297863/
https://www.ncbi.nlm.nih.gov/pubmed/30631408
http://dx.doi.org/10.4081/hr.2018.7753
work_keys_str_mv AT almegrenmosaad pulmonaryembolisminapatientwithneurolepticmalignantsyndrome